Clin Chem Lab Med. 2015 Apr;53(5):771-80. doi: 10.1515/cclm-2014-0354.
Trauma patients sustaining abdominal trauma exhibit high risk of organ failure and/or sepsis aggravating morbidity and mortality during the post-traumatic course. The present study re-evaluates L- and I-FABPs (small fatty acid binding proteins) as early biomarkers for abdominal injury (AI) in a large cohort of patients and analyzes their potential as indicators of specific organ failure and their association with sepsis and/or mortality in the post-traumatic course.
This prospective study included 134 multiply traumatized patients (ISS≥16). Fifty-nine had AI (abbreviated AI Scale, AISAbd≥3) and 75 had no AI (noAI). Twenty healthy volunteers served as controls. Plasma I- and L-FABP levels were measured at the admittance to the emergency room (d0) and up to 10 days daily (d1-d10) using ELISA. Sepsis, organ failure, multiple organ failure (MOF) and mortality were assessed.
Median L- and I-FABP in the AI-group [258 (IQR=71-500) ng/mL and 328 (IQR=148-640) pg/mL, respectively] were higher compared to noAI-group [30 (IQR=18-50) ng/mL and 60 (IQR=40-202) pg/mL, p>0.05] on d0. Sensitivity and specificity to detect AI were 80% and 75% for L-FABP, 78% and 62% for I-FABP. Both FABPs decline with the post-traumatic course to control levels. On d0 and d1, FABPs correlate with the Sepsis-related Organ Failure Assessment (SOFA) score of the following day (d0: ρ:0.33, ρ:0.46, d1: ρ:0.48, ρ:0.35). No other correlations were found. Eight percent of all patients developed sepsis, 18% pneumonia, 4% urinary tract infection, 3% acute kidney failure and one MOF. FABPs correlated neither with Simplifed Acute Physiology Score (SAPS)-II nor to sepsis. All patients with acute kidney failure demonstrated enhanced L-FAPB levels before the increase of serum creatinine levels.
Our results confirm the potential of L- and I-FABP to indicate abdominal injuries initially after trauma. Except L-FABP as indicator of acute kidney failure both FABPs have to be further evaluated as predictors for other organ failures, sepsis and/or mortality.
遭受腹部创伤的创伤患者在创伤后过程中表现出高器官衰竭和/或脓毒症加重发病率和死亡率的风险。本研究在大量患者中重新评估了 L- 和 I-FABP(小脂肪酸结合蛋白)作为腹部损伤(AI)的早期生物标志物,并分析了它们作为特定器官衰竭指标的潜力及其与创伤后脓毒症和/或死亡率的关系。
这项前瞻性研究包括 134 名多发性创伤患者(ISS≥16)。59 例有 AI(缩写为 AI 量表,AISAbd≥3),75 例无 AI(无 AI)。20 名健康志愿者作为对照。在急诊科就诊时(d0)和每天最多 10 天(d1-d10)使用 ELISA 测量血浆 I- 和 L-FABP 水平。评估脓毒症、器官衰竭、多器官衰竭(MOF)和死亡率。
AI 组的中位 L- 和 I-FABP [258(IQR=71-500)ng/mL 和 328(IQR=148-640)pg/mL]高于无 AI 组 [30(IQR=18-50)ng/mL 和 60(IQR=40-202)pg/mL,p>0.05]。d0 时,L-FABP 检测 AI 的灵敏度和特异性分别为 80%和 75%,I-FABP 分别为 78%和 62%。两种 FABP 均随创伤后过程而下降至对照水平。在 d0 和 d1,FABP 与次日的脓毒症相关器官衰竭评估(SOFA)评分相关(d0:ρ:0.33,ρ:0.46,d1:ρ:0.48,ρ:0.35)。未发现其他相关性。所有患者中,8%发生脓毒症,18%发生肺炎,4%发生尿路感染,3%发生急性肾衰,1 例发生 MOF。FABP 与简化急性生理学评分(SAPS)-II 或脓毒症均无相关性。所有发生急性肾衰的患者在血清肌酐水平升高前均表现出增强的 L-FAPB 水平。
我们的结果证实了 L- 和 I-FABP 在创伤后最初指示腹部损伤的潜力。除了 L-FABP 作为急性肾衰的指标外,两种 FABP 均需进一步评估作为其他器官衰竭、脓毒症和/或死亡率的预测因子。